IFNG and myocarditis: Based on research findings presented here, we suggest that increasing the time interval between the first and second vaccines doses could potentially reduce or eliminate myocarditis adverse events by reducing the chances of unfavorable synergism on interferon-gamma secretion resulting from the successive waves of primary responses.